Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) has obtained approval from the China Securities Regulatory Commission to issue H shares.
Huaheng Biotechnology (688639.SH) announced that the company is applying to issue overseas listed shares (H shares) and list on the main board of the Hong Kong Stock Exchange. The company recently received a notice from the China Securities Regulatory Commission regarding the approval for Anhui Huaheng Biotechnology Co., Ltd. to issue overseas listed shares (national letter [2026] 705). The company plans to issue up to 31.9593 million ordinary shares for overseas listing and listing on the Hong Kong Stock Exchange.
Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) announced that the company is applying for the issuance of overseas listed shares (H shares) and listing on the main board of the Hong Kong Stock Exchange. The company recently received the "Notice of Approval for Overseas Issuance and Listing of Anhui Huaheng Biotechnology Co., Ltd. Technology Stock Co., Ltd." (Guohe Letter [2026] 705) issued by the China Securities Regulatory Commission. The company plans to issue up to 31.9593 million overseas listed ordinary shares and list on the Hong Kong Stock Exchange.
Related Articles
Liaoning Port (02880) has a public shareholding proportion below the required level, and the Hong Kong Stock Exchange has agreed to a transitional arrangement.
TRULY INT'L (00732) spent 970,000 Hong Kong dollars to repurchase 1 million shares on April 2nd.
CHINA OVERSEAS (00688): "22zhonghai02" will pay interest on April 7th.
Liaoning Port (02880) has a public shareholding proportion below the required level, and the Hong Kong Stock Exchange has agreed to a transitional arrangement.
TRULY INT'L (00732) spent 970,000 Hong Kong dollars to repurchase 1 million shares on April 2nd.
CHINA OVERSEAS (00688): "22zhonghai02" will pay interest on April 7th.
